PCM
ASTH icon

Prelude Capital Management’s Astrana Health ASTH Stock Holding History

Prelude Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,382
Closed -$351K – 1605
2025
Q3 		$351K Buy
+12,382
New +$336K 0.03% 649
2025
Q1 		– Sell
-7,284
Closed -$230K – 1577
2024
Q4 		$230K Buy
+7,284
New +$346K 0.01% 927
2021
Q4 		– Sell
-14,873
Closed -$1.35M – 2306
2021
Q3 		$1.35M Buy
+14,873
New +$1.26M 0.03% 444
2020
Q4 		– Sell
-500
Closed -$9K – 2091
2020
Q3 		$9K Buy
+500
New +$8.63K ﹤0.01% 1475
2019
Q1 		– Sell
-419
Closed -$8K – 2260
2018
Q4 		$8K Hold
419
– – ﹤0.01% 1433
2018
Q3 		$9K Buy
+419
New +$8.82K ﹤0.01% 1489

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prelude Capital Management's ASTH Position: Q4 2025 in Review

Prelude Capital Management sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 12,382 shares — an estimated $351K sold.

Prelude Capital Management first reported a position in ASTH in Q3 2018 and held it in 6 quarters. The position peaked at $1.35M in Q3 2021. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Prelude Capital Management reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 12,382 Astrana Health shares in Q4 2025, an estimated $351K.
  • Prelude Capital Management first reported a position in Astrana Health in Q3 2018 and held it in 6 quarters.
  • Prelude Capital Management's Astrana Health position peaked at $1.35M in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.